Get the Stockscreener App
17.43
0.23%
0.04
After Hours:
17.43
Anika Therapeutics Inc stock is traded at $17.43, with a volume of 83,042.
It is up +0.23% in the last 24 hours and up +6.87% over the past month.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
See More
Previous Close:
$17.39
Open:
$17.95
24h Volume:
83,042
Relative Volume:
1.14
Market Cap:
$255.27M
Revenue:
$166.88M
Net Income/Loss:
$-74.18M
P/E Ratio:
-3.4379
EPS:
-5.07
Net Cash Flow:
$1.14M
1W Performance:
-2.41%
1M Performance:
+6.87%
6M Performance:
-31.89%
1Y Performance:
-32.68%
1-Day Range:
$17.32
$18.07
1-Week Range:
$17.32
$18.34
52-Week Range:
$15.40
$29.11
Anika Therapeutics Inc Stock (ANIK) Company Profile
Name
Anika Therapeutics Inc
Sector
Phone
(781) 457-9000
Address
32 WIGGINS AVENUE, BEDFORD, MA
Compare ANIK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
17.43 | 255.27M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
165.31 | 74.02B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.15 | 45.90B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.08 | 44.64B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.23B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.57 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-01-24 | Reiterated | Barrington Research | Outperform |
| Aug-14-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-07-23 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Nov-09-22 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-14-22 | Resumed | Stephens | Equal-Weight |
| Mar-09-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-09-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-16-21 | Initiated | Stephens | Overweight |
| Jul-16-21 | Initiated | UBS | Neutral |
| Dec-16-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-08-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jan-21-20 | Upgrade | Sidoti | Neutral → Buy |
| Jan-10-20 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Nov-05-19 | Initiated | BWS Financial | Sell |
| Sep-24-19 | Reiterated | Barrington Research | Outperform |
| Sep-23-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Strong Buy |
| Feb-22-19 | Downgrade | First Analysis Sec | Outperform → Neutral |
| Feb-22-19 | Downgrade | Sidoti | Buy → Neutral |
| Jul-27-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jun-20-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-20-18 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| May-04-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-23-18 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jan-24-18 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Oct-27-17 | Reiterated | Barrington Research | Outperform |
| May-09-16 | Upgrade | Singular Research | BUY - Long-Term → Buy |
| Apr-27-16 | Downgrade | Northland Capital | Outperform → Market Perform |
| Feb-26-16 | Reiterated | Barrington Research | Outperform |
View All
Anika Therapeutics Inc Stock (ANIK) Latest News
How to Take Advantage of moves in (ANIK) - Stock Traders Daily
SG Americas Securities LLC Reduces Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Global Hyaluronic Acid for Osteoarthritis Market Reached - openPR
Viscosupplementation Market Global Forecast Report and Company Analysis 2025-2033 Featuring Anika Therapeutics, Zimmer Biomet, Smith & Nephew, F.Hoffmann-La Roche, Sanofi, Chugai, Lifecore, LGResearchAndMarkets.com | FinancialContent Busi - Financial Content
Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 48%? - Yahoo Finance
BlackRock, Inc. Reduces Stake in Anika Therapeutics Inc - GuruFocus.com
Trading (ANIK) With Integrated Risk Controls - news.stocktradersdaily.com
JPMorgan Chase & Co. Sells 11,072 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Dimensional Fund Advisors LP Reduces Stake in Anika Therapeutics Inc - GuruFocus.com
Facial Aesthetics Market Generated Opportunities, Future - openPR
Orthopedic Digit Implants Market: Share, Revenue Insights, - openPR
Barclays PLC Purchases 13,054 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Viscosupplementation Market Generated Opportunities, Future - openPR
(ANIK) Proactive Strategies - Stock Traders Daily
Anika Therapeutics stock hits 52-week low at $15.8 By Investing.com - Investing.com Australia
Anika Therapeutics stock hits 52-week low at $15.8 - Investing.com India
Jane Street Group LLC Increases Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Geode Capital Management LLC - Defense World
Barclays PLC Buys 13,054 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
We Think Anika Therapeutics (NASDAQ:ANIK) Can Easily Afford To Drive Business Growth - Yahoo Finance
State Street Corp Sells 7,667 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Bought by HighTower Advisors LLC - Defense World
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Anika Therapeutics to Present at JPM Healthcare Conference 2025: Joint Preservation Leader Takes Stage - StockTitan
(ANIK) On The My Stocks Page - Stock Traders Daily
Fmr LLC Acquires 4,996 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Improved Revenues Required Before Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Find Their Feet - Simply Wall St
Anika Therapeutics stock hits 52-week low at $15.99 - Investing.com
Verition Fund Management LLC Sells 1,763 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest Update - MarketBeat
Knee Osteoarthritis Market Projected CAGR 12.5% Dynamics - openPR
Joint Pain Injection Market Expected to Reach Prominent Growth - openPR
ANIK (Anika Therapeutics) Net Issuance of Preferred Stock : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Osteoarthritis Therapeutics Market Size to Reach USD 24.34 Bn by 2034 - GlobeNewswire Inc.
Anika To Participate in December 2024 Investor Conferences - The Manila Times
Anika Therapeutics to Present at Three Major Healthcare Investor Conferences in December | ANIK Stock News - StockTitan
Orthopedic Regenerative Surgical Products Market to Witness - openPR
Joint Pain Injection Market Size, Share, Trends, - openPR
New Strong Sell Stocks for November 11th - Yahoo Canada Finance
Orthobiologics Market Size, Growth, Opportunities 2024-2032 | - openPR
Anika Therapeutics Navigates Geopolitical Risks Amid Global Conflicts - TipRanks
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Capital Management Corp VA - MarketBeat
Anika Therapeutics Announces Third Quarter Financial ResultsOn October 31, 2024, Anika Therapeutics, Inc. released a press statement unveiling its financial outcomes for the third quarter concluding on September 30, 2024. As per the report - Defense World
Viscosupplementation Market Report Analysis, Growth - openPR
Anika Therapeutics (NASDAQ:ANIK) Downgraded to Hold Rating by StockNews.com - MarketBeat
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2024 Earnings Call Transcript - Insider Monkey
Barrington Research Cuts Anika Therapeutics (NASDAQ:ANIK) Price Target to $25.00 - Defense World
Earnings call: Anika Therapeutics Focuses on HA Products Amid Restructuring By Investing.com - Investing.com South Africa
Earnings call: Anika Therapeutics Focuses on HA Products Amid Restructuring - Investing.com
Anika Therapeutics Inc Stock (ANIK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.92%
1.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):